A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation.
Mol Pharm
; 16(9): 3926-3937, 2019 09 03.
Article
in En
| MEDLINE
| ID: mdl-31287952
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
Immunoconjugates
/
Cysteine
/
Lysine
/
Maytansine
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2019
Document type:
Article
Country of publication: